Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Stella Pharma Corporation
No Price
Closing Price XTKS 01.05.2026:
531,00 JPY
01.05.2026 05:39
Current Prices from Stella Pharma Corporation
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
4888.T
JPY
01.05.2026 05:39
531,00 JPY
17,00 JPY
+3,31 %
Share Float & Liquidity
Free Float60,93 %
Shares Float20,73 M
Shares Outstanding34,02 M
Company Profile for Stella Pharma Corporation Share
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.
